INHSU 2027

7-10 SEPTEMBER 2026

Hilton Mexico City Reforma
Mexico

The 15th International Conference
on Health, Hepatitis
and Substance Users

Sign up for alerts

What to expect

 

300+ sessions

Tracks on Epidemiology and Public Health Research, Clinical Research, Social Science and Policy Research, and Models of Care and Programs.

Cross collaboration

Plenaries, interactive workshops, community-led sessions, discussion space, poster presentations, and a day of topic-specific preconference events.

Diverse topics

Sessions on everything from harm reduction innovations to HIV, HCV, HBV, TB and other infections, other drug-related harms, drug policy, and more.

 Interactive format

People who use drugs, advocates, healthcare providers, researchers, and policymakers contribute with equal voice and influence.

Why Mexico City?

 

Mexico City is a natural place to bring the global community together.

Across Latin America, researchers, clinicians, peer workers and communities have decades of experience responding to evolving drug markets and developing innovative approaches to harm reduction that address a wide range of health and social harms. This includes addressing health impacts of stimulant use, preventing and treating HIV and hepatitis C, harm reduction associated with smoking drugs, navigating policy reform, and strengthening community-led responses.

The conference also reflects the growing momentum of INHSU’s engagement across the region, including the establishment of a dedicated Latin American Working Group to strengthen collaboration and knowledge exchange.

As our first conference in Latin America, Mexico provides an accessible destination for delegates from across the Americas, Europe and beyond, creating new opportunities to strengthen global collaboration and experience one of the world’s most vibrant and culturally rich regions.